These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 16817818)

  • 1. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adrenal hyperplasia of late onset: optimization of therapy by measuring the circadian variation of serum 17-OH-progesterone].
    Contreras P; Rojas A; Vega I
    Rev Med Chil; 1989 Jun; 116(6):552-7. PubMed ID: 2749040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new less-invasive and more informative low-dose ACTH test: salivary steroids in response to intramuscular corticotrophin.
    Contreras LN; Arregger AL; Persi GG; Gonzalez NS; Cardoso EM
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):675-82. PubMed ID: 15579180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
    Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM; Jenkins RC; Rostami-Hodjegan A; Newell-Price J; Doane A; Ibbotson V; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2004 Sep; 61(3):367-75. PubMed ID: 15355454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency.
    Agha A; Liew A; Finucane F; Baker L; O'Kelly P; Tormey W; Thompson CJ
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):688-93. PubMed ID: 15163331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel strategies for hydrocortisone replacement.
    Debono M; Price JN; Ross RJ
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion.
    Bryan SM; Honour JW; Hindmarsh PC
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3477-80. PubMed ID: 19567522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose ACTH (1 microg) salivary test: a potential alternative to the classical blood test.
    Marcus-Perlman Y; Tordjman K; Greenman Y; Limor R; Shenkerman G; Osher E; Stern N
    Clin Endocrinol (Oxf); 2006 Feb; 64(2):215-8. PubMed ID: 16430723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusion of epinephrine decreases serum levels of cortisol and 17-hydroxyprogesterone in patients with rheumatoid arthritis.
    Straub RH; Kittner JM; Heijnen C; Schedlowski M; Schmidt RE; Jacobs R
    J Rheumatol; 2002 Aug; 29(8):1659-64. PubMed ID: 12180725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
    Björnsdottir S; Øksnes M; Isaksson M; Methlie P; Nilsen RM; Hustad S; Kämpe O; Hulting AL; Husebye ES; Løvås K; Nyström T; Bensing S
    Clin Endocrinol (Oxf); 2015 Jul; 83(1):28-35. PubMed ID: 25400085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers.
    Newell-Price J; Whiteman M; Rostami-Hodjegan A; Darzy K; Shalet S; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2008 Jan; 68(1):130-5. PubMed ID: 17803699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency.
    Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry.
    Kao PC; Machacek DA; Magera MJ; Lacey JM; Rinaldo P
    Ann Clin Lab Sci; 2001 Apr; 31(2):199-204. PubMed ID: 11337910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
    Oksnes M; Björnsdottir S; Isaksson M; Methlie P; Carlsen S; Nilsen RM; Broman JE; Triebner K; Kämpe O; Hulting AL; Bensing S; Husebye ES; Løvås K
    J Clin Endocrinol Metab; 2014 May; 99(5):1665-74. PubMed ID: 24517155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion.
    Bliesener N; Steckelbroeck S; Redel L; Klingmüller D
    Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):443-6. PubMed ID: 14614652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile Subcutaneous Hydrocortisone Replacement in Primary Adrenal Insufficiency.
    Simunkova K; Løvås K; Methlie P; Jovanovic N; Bifulco E; Bronstad I; Lightman SL; Husebye ES; Oksnes M
    Horm Metab Res; 2023 Jul; 55(7):471-478. PubMed ID: 37172949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
    Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.